Valens is trading 6.25% up at $1.81 after its August 12, 2026 earnings release raised full-year revenue guidance to $78.0 million-$81.0 million.

  • The midpoint implies approximately 13% growth over 2025 revenue.
  • Third-quarter revenue was guided to $21.3 million-$21.7 million.
  • Adjusted EPS met expectations at a $0.04 loss, while the guidance increase outweighed near-term profitability concerns.